Sign in

Matthew Herm

Research Analyst at Matthew Herm LLC

Matthew Herm is an analyst at Matthew Herm LLC, specializing in equity research and financial analysis. He has covered companies such as iBio, directly engaging with corporate earnings calls to provide detailed insights for investors. Herm has an emerging track record, having contributed qualitative analysis within his firm but without widely published performance metrics or sector rankings. While his career specifics, prior experience, and professional credentials such as FINRA registration or securities licenses are not publicly documented, Herm maintains an active presence in equity research and frequently participates in earnings events.

Matthew Herm's questions to iBio (IBIO) leadership

Question · Q2 2022

Matthew Herm of Matthew Herm LLC questioned the Board's recent resolutions to change shareholder voting requirements, asking if these changes were related to future plans for proposals like an increase in authorized shares or a reverse stock split.

Answer

CEO Tom Isett explained that the resolutions are a response to structural challenges and low voter turnout common among companies with large retail shareholder bases. He clarified that these issues make it difficult to achieve a quorum for annual meetings. Tom Isett confirmed the changes are intended to enable the company to conduct its business effectively and are related to putting iBio in a better position to pass proposals, such as the previously supported reverse split and share authorization increase, which failed due to insufficient vote count.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts